PfizerPFE
NYSEPharmaceuticals
No cached AI snapshot yet for PFE.
Be the first to run a multi-agent analysis on this ticker.
Key Stats
75,000 employees5.69B shares outstandingdividend yield 6.49%
Next earnings ~May 5, 2026 · Ex-dividend May 8, 2026 · Dividend $0.43 quarterly
About Pfizer
Pfizer is one of the world's largest pharmaceutical firms, with annual sales of roughly $60 billion. While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13 and cardiology drugs Vyndaqel and Eliquis. Pfizer sells these products globally, with international sales representing 40% of total sales. Within international sales, emerging markets are a major contributor.
Latest News
Should You Forget This High-Yield Pharma Stock and Buy a Growth Name Instead?
Pfizer Says Cancer Therapy Beats Standard Therapy In Late-Stage Blood Cancer Study
Pfizer posts late-stage trial win for multiple myeloma therapy Elrexfio
Retatrutide Crosses the Surgical Threshold, but the Real Race Has Just Started
Are Wall Street Analysts Bullish on Pfizer Stock?
Antibiotic Resistance Market to Grow at 5.4% CAGR Reaching USD 12.72 Billion by 2031, Driven by Rising Drug-Resistant Infections and Antimicrobial Innovation: Mordor Intelligence
Related Stocksin Pharmaceuticals
Ready to see the live AI view on PFE?
Launch a real-time multi-agent room — Claude, GPT, Gemini, DeepSeek, Grok, and Qwen analyzing PFE side-by-side with live signals.